Adjuvant chemotherapy for bile duct cancer after surgery
Treatments studied
This study tests whether giving chemotherapy directly into the liver (HAIC) plus an oral chemo pill (capecitabine) after surgery helps prevent bile duct cancer from coming back, compared to just the pill. It's for people who recently had their cancer completely removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with bile duct or gallbladder cancer that was completely removed by surgery
- You have not had any other cancer treatments (like chemo, radiation, or immunotherapy) before or after your surgery
- You are in good overall health (able to do daily activities)
- Your blood counts and liver/kidney function are within acceptable levels
- You agree to use birth control during the study and for 6 months after (if applicable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specific chemotherapy after surgery for people with stage II or III bile duct, gallbladder, or ampullary cancer. It may help reduce the chance of cancer coming back.
This trial compares two types of chemotherapy for people whose bile duct cancer has come back after surgery. It tests if a combination of irinotecan liposomes, 5-FU, and leucovorin works better than the standard pill capecitabine.
This trial tests a combination of chemotherapy directly into the liver artery, an immunotherapy drug, and a targeted therapy pill before surgery for a type of bile duct cancer that has a high chance of coming back. The goal is to see if this approach can improve outcomes for patients whose cancer is still removable but has certain high-risk features.
This trial tests combining two drugs (adebrelimab and lenvatinib) with a liver-directed chemotherapy infusion (HAIC) to shrink locally advanced bile duct or gallbladder cancers enough to allow surgery. It is for people who haven't had prior treatment for their biliary cancer and whose cancer has not spread far.
This study tests whether combining chemotherapy and radiation therapy after surgery improves outcomes for patients with bile duct or gallbladder cancer. It's designed for patients whose surgery showed signs the cancer might come back.
This trial tests a personalized cancer vaccine combined with chemotherapy to help prevent bile duct cancer from coming back after surgery. It is for people who had their tumor removed but have a high risk of recurrence.
Hear when a new Malignant Biliary Tract Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.